Elicio Therapeutics ELTX
NASDAQ ELTX
$1.61 +0.04 (+2.55%)
As of: Oct 21, 2026 · 11:34 AM EDT

Elicio Therapeutics (ELTX) Current Leases (2021 - 2022)

Updated

Elicio Therapeutics (ELTX) recorded Current Leases of $67,000 in Q4 2022, up 15.5% from $58,000 a year earlier and up 4.7% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Current Leases (2021 - 2022) Analysis & Trends

Starting with Q4 2021, Elicio Therapeutics' Current Leases history includes 5 quarters.

  • Across earlier years, Current Leases came in at $58,000 in FY2021.
  • Per Business Quant, the preceding three quarters came in at $64,000 (Q3 2022), $62,000 (Q2 2022) and $60,000 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn -
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn -
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn -
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn -
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -
10 Elicio Therapeutics 30.98 Mn -46.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 67,000.00
Sep 30, 2022 64,000.00
Jun 30, 2022 62,000.00
Mar 31, 2022 60,000.00
Dec 31, 2021 58,000.00
API Access

Elicio Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ELTX&period=max&api_key=YOUR_API_KEY